Contact Us

Pano Therapeutics welcomes inquiries from prospective partners, investors, scientific and clinical collaborators, and the patient-advocacy community working in Fragile X Syndrome and related neurodevelopmental disorders.

For partnering, business development, investor relations, and scientific collaboration, please contact Ben Gibson, Chief Executive Officer and Co-founder, at ben@panotherapeutics.com or via the form below.